Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood.
about
Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical TrialsMilestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current DevelopmentsAllogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord bloodAlternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Prognosis and outcome of stem cell transplantation for mantle cell lymphoma.Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols.Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord blood.Are alternative donors really still "alternative?".Advances in umbilical cord blood transplant: an overview of the 12th International Cord Blood Symposium, San Francisco, 5-7 June 2014.Unrelated Cord Blood Transplantation in adults: evolution, experience and long-term outcomes in the UK National Health Service : a retrospective analysis on behalf of the British Society of Blood and Marrow Transplantation and Eurocord.Is umbilical cord milking always an advantage?Expansion of NKG2C-expressing Natural Killer Cells after Umbilical Cord Blood Transplantation in a Patient with Peripheral T-cell Lymphoma with Cytotoxic Molecules.
P2860
Q26772216-7F9F02CD-41BB-407F-8A76-9D948101AD9DQ28067102-C6224760-B14B-449A-AEE4-49BF7F9C03F3Q34374133-421031CB-BDCA-4D78-A195-3F51EBA58D02Q35108791-E665A4E7-1FD2-4A7C-916D-7383CE29B364Q38387292-F27DE1A9-39CB-4BB7-8FD3-55464C0F9437Q38532268-F5C740B0-AC46-4B39-9094-25F1C2FC5BB1Q38636111-7AF1AD83-B9AE-489C-8CA8-D2188D80C649Q38952071-0BBB841C-9915-4677-88CB-79F869C3E991Q40618397-28994603-8D6F-406B-996E-F9AB5EA0C6DEQ40763299-9784714E-F9A0-4AA7-AF07-CC61A7274D5FQ41185627-95A857A7-BEF9-4823-A739-A36A1178BD52Q43668394-FA04343B-9C90-446C-B165-0D518F4370B8Q47569026-5CEF5BA3-8454-4DD7-BEAA-1861542A326FQ53597704-E6B3C323-DCCD-4BC0-BAEA-DD2255345699Q54560297-EAD2E43C-DED7-4E36-B46D-A60019253519
P2860
Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alternative donor hematopoieti ...... elated donor peripheral blood.
@en
Alternative donor hematopoieti ...... elated donor peripheral blood.
@nl
type
label
Alternative donor hematopoieti ...... elated donor peripheral blood.
@en
Alternative donor hematopoieti ...... elated donor peripheral blood.
@nl
prefLabel
Alternative donor hematopoieti ...... elated donor peripheral blood.
@en
Alternative donor hematopoieti ...... elated donor peripheral blood.
@nl
P2093
P2860
P50
P1433
P1476
Alternative donor hematopoieti ...... related donor peripheral blood
@en
P2093
Anna Sureda
Arnon Nagler
Bernard Rio
Carmen Canals
Celso Arrais Rodrigues
Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Claudio Brunstein
Dietger Niederwieser
Eefke Petersen
Eurocord-Netcord and the Lymphoma Working Party
P2860
P304
P356
10.3324/HAEMATOL.2013.088997
P577
2013-08-09T00:00:00Z